EDWARDS LIFESCIENCES, LLC for EDWARDS LIFESCIENCES LLC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Ensuring Patient Access to Critical Breakthrough Products (S.1717) Transitional Coverage for Emerging Technologies (TCET) Guidance Policies promoting medical innovation Heart Valve Disease Awareness AI in Healthcare FDA Reauthorization for 2022/FDA User Fees Diversity in Clinical Trials Coverage with Evidence Development
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BRIAN LOOSER | — |
| MEGHAN O'BRIEN | — |
Medicare/Medicaid MMM
CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (s.1717) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BRIAN LOOSER | — |
| MEGHAN O'BRIEN | — |
Taxation/Internal Revenue Code TAX
Corporate Tax Reform Proposals
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BRIAN LOOSER | — |
Trade (domestic/foreign) TRD
Tariffs
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH RAYE KEGLER | — |
| BRIAN LOOSER | — |
| MEGHAN O'BRIEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.